» Educational Qualifications

» Publications

SCI-SSCI or SCI Expanded Articles

  • Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis. Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. (December 2023)
  • Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials. Flack JM, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Adler SG, Fried L, Jamerson K, Toto R, Brinker M, Farjat AE, Kolkhof P, Lawatscheck R, Joseph A, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Kidney Med. 2023 Sep 28;5(12):100730. doi: 10.1016/j.xkme.2023.100730. eCollection 2023 Dec. PMID: 38046911 (December 2023)
  • Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon‐like peptide‐1 receptor agonist use. Rossing P, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Fonseca V, Umpierrez GE, Caramori ML, Joseph A, Lambelet M, Lawatscheck R, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Diabetes Obes Metab. 2023 Feb;25(2):407-416. doi: 10.1111/dom.14883. (November 2023)
  • Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis. Rosas SE, Ruilope LM, Anker SD, Pitt B, Rossing P, Bonfanti AAC, Correa-Rotter R, González F, Munoz CFJ, Pergola P, Umpierrez GE, Scalise A, Scott C, Lawatscheck R, Joseph A, Bakris GL; FIDELIO-DKD and FIGARO-DKD investigators. Kidney Med. 2023 Aug 1;5(10):100704. doi: 10.1016/j.xkme.2023.100704. eCollection 2023 Oct. PMID: 37745646 (October 2023)
  • The effects of angiotensinogen M235T/T174M and angiotensin type 1 receptor a1166c gene polymorphisms on the development of diabetic nephropathy in type 2 diabetes mellitus patients. Yukcu F, Sipahi T, Guldiken S, Ustundag S, Sut N. Bratisl Lek Listy. 2023;124(3):175-181. doi: 10.4149/BLL_2023_028. (March 2023)
  • Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline. McGill JB, Agarwal R, Anker SD, Bakris GL, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, Caramori ML, Brinker M, Joseph A, Lage A, Lawatscheck R, Scott C, Rossing P; FIDELIO-DKD and FIGARO-DKD investigators. Diabetes Obes Metab. 2023 Jun;25(6):1512-1522. doi: 10.1111/dom.14999. Epub 2023 Feb 26. PMID: 36722675 (February 2023)
  • A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes. Bakris GL, Ruilope LM, Anker SD, Filippatos G, Pitt B, Rossing P, Fried L, Roy-Chaudhury P, Sarafidis P, Ahlers C, Brinker M, Joseph A, Lawatscheck R, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Kidney Int. 2023 Jan;103(1):196-206. doi: 10.1016/j.kint.2022.08.040. Epub 2022 Oct 28. PMID: 36367466 (January 2023)
  • Ruilope LM, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, Schmieder RE, Joseph A, Rethemeier N, Nowack C, Bakris GL; FIDELIO-DKD Investigators.Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes. Hypertension. 2022 Dec;79(12):2685-2695. doi: 10.1161/HYPERTENSIONAHA.122.19744. (November 2022)
  • Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis (November 2022)
  • Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial (November 2022)
    31
    ATIF
  • Trends of primary glomerular disease in Turkey: TSN-GOLD registry report. INTERNATIONAL UROLOGY AND NEPHROLOGY; 2022; Volume 54 Issue 9, Page 2285-2294 DOI10.1007/s11255-022-03123-6 (September 2022)
  • The role of eNOS gene polymorphisms on contrast induced nephropathy development in chronic kidney disease patients. THERAPEUTIC APHERESIS AND DIALYSIS 2022 DOI10.1111/1744-9987.13921 Early Access AUG 2022 Indexed2022-09-07 (August 2022)
  • Investigation of the Relationship Between IL-18 (-607 C/A), IL-18 (-137 G/C), and MMP-2 (-1306 C/T) Gene Variations and Serum Copper and Zinc Levels in Patients Diagnosed with Chronic Renal Failure. BIOLOGICAL TRACE ELEMENT RESEARCH; 2022 Volume 200, Issue5, Page2040-2052 DOI10.1007/s12011-021-02828-6 (May 2022)
    2
    ATIF
  • Rossing P, Burgess E, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Gillard P, MacIsaac RJ, Wainstein J, Joseph A, Brinker M, Roessig L, Scott C, Bakris GL; FIDELIO-DKD Investigators. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care. 2022 Apr 1;45(4):888-897. doi: 10.2337/dc21-1944. PMID: 35061867 (April 2022)
  • Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, . Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23.PMID: 33264825 (October 2020)
    162
    ATIF
  • Ruilope LM, Agarwal R, Anker SD, Bakris GL, Filippatos G, Nowack C, Kolkhof P, Joseph A, Mentenich N, Pitt B; FIGARO-DKD study investigators. Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial. Am J Nephrol. 2019;50(5):345-356. doi: 10.1159/000503712. Epub 2019 Oct 30. (November 2019)
    20
    ATIF
  • Investigation of the relationship between MTHFR, IRS and CALCA gene polymorphisms and development of diabetic nephropathy in patients with type 2 diabetes mellitus (January 2019)
  • Macdougall, Iain C.; Bock, Andreas H.; Carrera, Fernando; et al. Group Author(s): FIND-CKD Study Investigators. Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial. CLINICAL NEPHROLOGY 2017; 88:301-310 (December 2017)
    7
    ATIF
  • .D. S. ROGER, A. C. GAILLARD, H. A. BOCK, F. CARRERA, K. ECKARDT, D. W. VAN, M. CRONIN, Y. MEIER, S. LARROQUE, C. I. MACDOUGALL, S. ÜSTÜNDAG, Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial, Nephrology Dialysis Transplantation, vol. 32, no. 9, pp. 1530-1539, 2, 2017. (February 2017)
    11
    ATIF
  • .C. I. MACDOUGALL, H. A. BOCK, F. CARRERA, K. ECKARDT, C. GAILLARD, D. W. VAN, Y. MEIER, S. LARROQUE, D. S. ROGER, S. ÜSTÜNDAG, Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial, BMC Nephrology, vol. 18, no. 1, pp. 1-18, 1, 2017.
    5
    ATIF
  • Üstündağ S, Doğan E, Duranay M, Kazancıoğlu R, Çelik V, Ünsal A, Altıntepe L, Dursun B, Akbaş E, Özdener F, Yıldız A. Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anemia in Predialysis Patients. Balkan Med J 2016; 33: 322-330 (May 2016)
  • .S. ÜSTÜNDAG, E. DOGAN, M. DURANAY, R. KAZANCIOGLU, V. A. ÇELIK, A. ÜNSAL, L. ALTINTEPE, B. DURSUN, E. AKBAS, F. ÖZDENER, A. YILDIZ, Subcutaneous C E R A for the Treatment of Chronic Renal Anemia in Predialysis Patients, Balkan Medical Journal, vol. 33, no. 3, pp. 322-330, ISTANBUL-TÜRKIYE, 5, 2016.
  • Ustundag S, Yilmaz G, Sevinc C, Akpinar S, Temizoz O, Sut N, Ustundag A. Carotid intima media thickness is independently associated with urinary sodium excretion in patients with chronic kidney disease. Ren Fail. 2015;37(8):1285-92 (September 2015)
    2
    ATIF
  • Yilmaz G, Ustundag S, Temizoz O, Sut N, Demir M, Ermis V, Sevinc C, Ustundag A. Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease. Clin Lab. 2015;61(8):1061-70. (September 2015)
    3
    ATIF
  • Ustundag S, Ustun F, Yilmaz G, Narli E, Harari AA. Pleuroperitoneal Leak Complicating Continuous Ambulatory Peritoneal Dialysis: A Case Report. J Med Cases. 2015;6(3):101-104 (March 2015)
  • .S. ÜSTÜNDAG, G. YILMAZ, C. SEVINC, S. AKPINAR, O. TEMIZÖZ, N. SÜT, A. ÜSTÜNDAG, Carotid intima media thickness is independently associated with urinary sodium excretion in patients with chronic kidney disease Ren Fail 2015 37 8 1285 92, Renal Failure, vol. 37, no. 8, pp. 1285-1292, New York-AMERIKA BIRLESIK DEVLETLERI, 9, 2015.
    2
    ATIF
  • .G. YILMAZ, S. ÜSTÜNDAG, O. TEMIZÖZ, N. SÜT, M. DEMIR, V. ERMIS, C. SEVINÇ, A. ÜSTÜNDAG, Fibroblast Growth Factor 23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease, Clinical Laboratory, vol. 61, no. 8, pp. 1061-1070, 9, 2015.
    1
    ATIF
  • FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrol Dial Transplant. 2014;29:2075-84 (November 2014)
    134
    ATIF
  • The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale. Nephr Dial Transplant 2014 29; 843:850. (April 2014)
    29
    ATIF
  • ÇİÇİN İRFAN,ERDOĞAN BÜLENT,GÜLŞEN EMRAH,UZUNOĞLU SERNAZ,SÜT NECDET,TÜRKMEN ESRA,KODAZ HİLMİ,ÜSTÜNDAĞ SEDAT. Incidence of contrast induced nephropathy in hospitalised patients with cancer. European Radiology 2014; 24: 184-190. 10.1007/s00330-013-2996-6
    13
    ATIF
  • S. GÜRCAN, M. TIKVESLI, S. ÜSTÜNDAG, B. ENER, A Case Report on Aspergillus lentulus Pneumonia, Balkan Medical Journal, vol. 30, no. 4, pp. 429-431, 12, 2013. (December 2013)
    3
    ATIF
  • .M. KANTER, S. SEN, S. DÖNMEZ, C. AKTAS, S. ÜSTÜNDAG, M. ERBOGA, Protective effects of irbesartan and alpha lipoic acid in STZ induced diabetic nephropathy in rats, Renal Failure, vol. 32, no. 4, pp. 498-505, 5, 2010.
    3
    ATIF
  • .C. KAVALCI, F. B. GÜLDIKEN, S. GÜLDIKEN, S. ÜSTÜNDAG, Association of renal dysfunction with stroke subtypes in acute strokepatients, Hong Kong Journal of Emergency Medicine, vol. 17, no. 1, pp. 22-26, 1, 2010.
  • .M. KANTER, S. SEN, S. DÖNMEZ, C. AKTAS, S. ÜSTÜNDAG, M. ERBOGA, Protective effects of irbesartan and alpha lipoic acid in STZ induced diabetic nephropathy in rats, Renal Failure, vol. 32, no. 4, pp. 498-505, 5, 2010.
    2
    ATIF
  • .F. B. GÜLDIKEN, T. SIPAHI, S. GÜLDIKEN, S. ÜSTÜNDAG, M. BUDAK, N. TURGUT, H. ÖZKAN, Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in Turkish patients with ischemic stroke, Molecular Biology Reports, vol. 36, no. 6, pp. 1539-1543, 7, 2009. (June 2009)
    2
    ATIF
  • .S. ÜSTÜNDAG, S. SEN, Ö. YALÇIN, S. ÇIFTÇI, B. DEMIRKAN, M. TÜRE, L Carnitine Ameliorates Glycerol Induced Myoglobinuric Acute Renal Failure in Rats, Renal Failure, vol. 31, no. 2, pp. 124-133, 1, 2009. (February 2009)
    11
    ATIF
  • .T. SIPAHI, F. B. GÜLDIKEN, S. GÜLDIKEN, S. ÜSTÜNDAG, N. TURGUT, M. BUDAK, S. ÇAKINA, H. ÖZKAN, S. SENER, The Association of Gene Polymorphisms of the Angiotensin Converting Enzyme and Angiotensin II Receptor Type 1 with Ischemic Stroke in Turkish Subjects of Trakya Region, Trakya Üniversitesi Tip Fakültesi Dergisi, vol. 26, no. 1, pp. 1-8, 1, 2009.
  • Association of angiotensinogen T174M and M235T gene variants with development of hypertension in Turkish subjects of Trakya region. Biotechnology and Biotechnological Equipment 2008; 22: 984-989 (November 2008)
    3
    ATIF
  • .S. ÜSTÜNDAG, Ö. YALÇIN, S. SEN, Z. ÇUKUR, S. ÇIFTÇI, B. DEMIRKAN, Experimental Myoglobinuric Acute Renal Failure The Effect of Vitamin C, Renal Failure, vol. 30, no. 7, pp. 727-735, 1, 2008. (September 2008)
    8
    ATIF
  • Experimental myoglobinuric acute renal failure: the effect of vitamin C. Ren Fail. 2008; 30: 727-735 (September 2008)
    18
    ATIF
  • The effects of spironolactone on nephron function in patients with diabetic nephropathy. Ren Fail 2008; 30: 982-91 (January 2008)
    13
    ATIF
  • Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy. Ren Fail 2008; 30: 1023-33. Erratum in: Ren Fail. 2009;31(2):180. Saniye, Sen [corrected to Sen, Saniye]; Mehmet, Kanter [corrected to Kanter, Mehmet]; Sedat, Ustundag [corrected to Ustundag, Sedat]; Cevat, Aktas [corrected to Aktas, Cevat]; Omer, Yalcin [corrected to Yalcin, Omer]. (January 2008)
    2
    ATIF
  • .S. SEN, M. KANTER, S. ÜSTÜNDAG, C. AKTAS, H. DOGUTAN, Ö. YALÇIN, Effect of Angiotensin Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade on Streptozotocin Induced Diabetic Nephropathy, Renal Failure, vol. 30, no. 10, pp. 1023-1033, 1, 2008.
  • .S. ÜSTÜNDAG, Ö. YALÇIN, S. SEN, Z. ÇUKUR, S. ÇIFTÇI, B. DEMIRKAN, Experimental Myoglobinuric Acute Renal Failure The Effect of Vitamin C, Renal Failure, vol. 30, no. 7, pp. 727-735, 1, 2008.
    1
    ATIF
  • Yalcin, O., Üstündag, S., Sen, S., Usta, U., Huseyinova, G., Oz Puyan, F.,Kutlu, K., Tudan, M. The effects of enalapriland irbesartan in experimental diabetic nephropathy. Biotechnology and Biotechnological Equipment. 2007; 21: 366-371 (August 2007)
    2
    ATIF
  • The relationship between the levels of plasma total homocysteine and insulin resistance in uncomplicated mild-to-moderate primary hypertension. J Hum Hypertens. 2006; 20: 379-81 (May 2006)
    12
    ATIF
  • Durmus-Altun G, Ustun F, Altun A, Ustundag S.Incidental diagnosis of asymptomatic pericardial effusion in uraemic patient by using 99mTc-MIBI perfusion SPECT. Nuklearmedizin. 2003; 42: N39-N41. (August 2003)
    3
    ATIF

International Articles

  • The roles of MTHFR (C677T, A1298C) and MGP (G-7A, T-138C) gene variations in development of diabetic nephropathy in patients with type 2 diabetes mellitus. JOURNAL OF DIABETES AND METABOLIC DISORDERS 2022; Volume21 Issue2; Page1317-1326 DOI10.1007/s40200-022-01061-9 (June 2022)
  • Ace gene polymorphisms are ineffective on contrast induced nephropathy. META GENE; 2022; Volume31 Article Number100992 DOI10.1016/j.mgene.2021.100992 (February 2022)
  • KILIÇ İLHAN,Gungor Kultural,KURULTAK İLHAN,ÜSTÜNDAĞ SEDAT. Relapsing Serratia peritonitis resulting in peritoneal catheter loss. 2018; 29:1494. 10.4103/1319-2442.248298 (November 2018)
  • Çoban Kılıç Vildan,ÜSTÜNDAĞ SEDAT,ÜSTÜNDAĞ AYTEN,SÜT NECDET. Effect of Six Months of Hemodialysis Treatment on Cognitive Function in Patients with End Stage Chronic Kidney Disease, 2018; 27, 178-188 (May 2018)
  • I. KILIÇ, I. KURULTAK, S. ÜSTÜNDAG, Atypical Presentation of Rectus Sheath Hematoma in a Hemodialysis Patient: Recurrent Abdominal Pain After Dialysis Sessions, Turkish Nephrology Dialysis Transplantation, vol. 26, no. 2, pp. 220-222, 5, 2017. (January 2017)
  • G. YILMAZ, C. SEVINC, S. ÜSTÜNDAG, C. Y. YAVUZ, E. HATIPOGLU, M. BAYSAL, The relationship between mean platelet volume and neutrophil/lymphocyte ratio with inflammation and proteinuria in chronic kidney disease, Saudi Journal of Kidney Diseases and Transplantation, vol. 28, no. 1, pp. 90-94, 1, 2017.
    6
    ATIF
  • .I. KILIÇ, I. KURULTAK, G. L. A. EGE, S. ÜSTÜNDAG, A. SARIKAYA, Scintigraphy as a Reliable Technique for Diagnosis and Follow Up of Pleuroperitoneal Leakage in Peritoneal Dialysis Patients, Turkish Nephrology Dialysis Transplantation, vol. 25, pp. 139-141, ISTANBUL-TÜRKIYE, 3, 2016.
  • .I. KURULTAK, I. KILIÇ, B. SEZER, A. S. TUNCEL, E. TASTEKIN, S. ÜSTÜNDAG, Endocarditis and Calcific Uremic Arteriolopathy Is it a Coincidence or an Association Case Report, Turkish Nephrology Dialysis Transplantation, vol. 25, pp. 113-117, ISTANBUL-TÜRKIYE, 3, 2016.
  • .S. ÜSTÜNDAG, F. ÜSTÜN, G. YILMAZ, E. NARLI, A. A. HARARI, Pleuroperitoneal Leak Complicating Continuous Ambulatory Peritoneal Dialysis A Case Report, Journal of Medical Cases, vol. 6, no. 3, pp. 101-104, 3, 2015.
  • .N. DUMAN, A. UYANIK, A. ÜNSAL, S. SEZER, T. ÇAMSARI, M. CIRIT, E. M. YILMAZ, B. ALTUN, D. MURAT, A. YILDIZ, I. SAHIN, A. DOGUKAN, S. ÜSTÜNDAG, I. KARAYAYLALI, K. ARZU, S. SÜKRÜ, A. A. KIYKIM, Y. YENIÇERIOGLU, E. AKBAS, F. ÖZDENER, Once monthly continuous erythropoietin receptor activator CERA for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia, Clinical Cidney Journal, vol. 7, no. 5, pp. 464-469, -INGILTERE, 7, 2014.
  • .K. A. KADIROGLU, S. ÜSTÜNDAG, Z. YILMAZ, S. SEN, E. M. YILMAZ, A comparative study of the effect of icodextrin based peritoneal dialysis and hemodialysis on lipid metabolism, Indian Journal of Nephrology, vol. 23, no. 5, pp. 358-361, 1, 2013.
  • İmmunglobulin A Nefropati. Turkiye Klinikleri Journal of Internal Medical Sciences 2006; 2: 37-48 (September 2006)
    2
    ATIF

International Conference Proceedings

  • THE EFFECT OF GLOMERULAR C3 DEPOSITION ON RENAL OUTCOME IN PATIENTS WITH MEMBRANOUS NEPHROPATHY: DATA OF THE TSN-GOLD STUDY Meltem Gursu1, Egemen Cebeci2, Aydin Turkmen3, ErkanDervisoglu4, Mehmet Sezen5, Kenan Turgutalp6, GulizarManga Sahin7, Sinan Trablus8, SimKutlay9, Sami Uzun2, Sedat Üstünda˘g10, Belda Dursun11, DenizAyli12, Erhan Tatar13, Kenan EvrenOztop14, Taner Basturk15, Simal Koksal Cevher16, Zulfikar Yilmaz17, Onur Tunca18, Mustafa Sevinç19, Serap Yadigar20, MuratDuranay21, Izzet Hakki Arikan22, Omer Celal Elcioglu1, ¸Sebnem Karakan23, Kultigin Turkmen24,25, Dilek Torun26, OzkanGungor27, Ayse Serra Artan3, SavasOzturk3, Abdülkadir Unsal15 and Nurhan Seyahi860th ERA-EDTA Congress. 15-18 June, 2023, Mılan, Italy, Nephrol Dial Transplant (2023) 38: i1–i103 https://doi.org/10.1093/ndt/gfad063 i407-i408 (June 2023)
  • IMMUNOSUPPRESSIVE TREATMENT RESULTS IN PATIENTS WITH PRIMARY IGA NEPHROPATHY IN TURKIYE: A NATIONWIDE STUDY , iAysegul Oruc1, Abdullah Sumnu2, Aydin Turkmen3, Taner Basturk4, Egemen Cebeci5, Kenan Turgutalp6, Hakkı Çetinkaya7,Muge Uzerk Kibar8, Nurhan Seyahi9, Erhan Tatar10,Metin Ergül11, Ülver Der˙Ic˙I12, Deniz Ayli13, Musa Pınar14, Betul Bakar15, Rumeyza Kazancioglu16, Abdulmecit Yildiz1, Ahmet Burak Dirim17, Zulfikar Yilmaz18, Kultigin Turkmen19, Onur Tunca20, Mehmet Koc21, Sim Kutlay22, Hasan Micozkadioglu23, AlperAzak24, Burcu Boztepe25, Sedat Üstünda˘g26, Seda Safak Ozturk3, Abdülkadir Unsal4, Serhat Karada˘g5, GulizarManga Sahin7, Ezgi Coskun Yenigun15, Necmi Eren11 andMustafa Gullulu1 60th ERA-EDTA Congress. 15-18 June, 2023, Mılan, Italy, Nephrol Dial Transplant (2023) 38: i1–i103 https://doi.org/10.1093/ndt/gfad063 i404 (June 2023)
  • KODAL NİL SU, KURULTAK İLHAN, KARAGÖZ FERDİ, ÜSTÜNDAĞ SEDAT. PULSE WAVE VELOCITY AND AMBULATORY BLOOD PRESSURE IN PATIENTS WITH RENAL HYPERFILTRATION. 60th ERA-EDTA Congress. 15-18 June, 2023, Mılan, Italy, Nephrol Dial Transplant (2023) 38: i1–i103 https://doi.org/10.1093/ndt/gfad063 i653 (June 2023)
  • N. ALKANLI, A. AY, S. ÜSTÜNDAG, N. SÜT, Investigation of the relationship between matrix gamma carboxyglutamicacid protein G-7A gene polymorphism genotype distributions and diabetic nephropathy development, 7th International Molecular Biology and Biotechnology Congress, 2018; pp. 125-125, Konya-TÜRKIYE.
  • Ay A, Alkanlı N, Sipahi T, Gülyaşar T, Üstündağ S, Güldiken S, Süt N. The role of IRS-1 Gly972Arg Gene Polymorphism Genotype Distribution in the Development of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients. Association of Thrace Universities 1st International Health Sciences Congress (December 2017)
  • .A. AY, N. ALKANLI, S. ÜSTÜNDAG, N. SÜT, The effect on the development of diabetic nephropathy of matrixgamma carboxyglutamic acid protein t138c gene polymorphismgenotype distributions in patients with type 2 diabetes melli, 6th INTERNATIONAL MOLECULAR BIOLOGY and BIOTECHNOLOGY CONGRESS. (December 2017)
  • N. ALKANLI, A. AY, T. SIPAHI, T. GÜLYASAR, S. ÜSTÜNDAG, S. GÜLDIKEN, N. SÜT, The Relationship Between MTHFR C677T Gene Polymorphism Genotype Distributions and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients, Association of Thrace Universities 1st International Health Sciences Congress, pp. 293-, EDIRNE-TÜRKIYE. (November 2017)
  • .P. HANDE, S. SEN, M. KANTER, S. ÜSTÜNDAG, C. AKTAS, Comparison of Irbesartan and combination with Nigella sativa oil in experimental diabetic nephropathy, 15. European Congress of Endocrinology, vol. 32, KOPENHAG-DANIMARKA.

International Books and Book Chapters

  • Olgularla Nefrolojik Aciller, Hipokalemi, pp 18-15. Güngör Ö, Arıcı M, Odabaş AR edts, Anakara Nobel Tıp Kitapevleri. 1. baskı 2023, Ankara, SBN: 978-605-6448-54-4 (October 2023)

National Articles

  • S. ÜSTÜNDAG, Acilde Hipertansiyon ve Tedavisi, Türkiye Klinikleri Journal of Nephrology, vol. 10, no. 1, pp. 45-54, 1, 2017. (July 2017)
  • Ç. KUZUGÜDEN, S. GÜLDIKEN, S. ÜSTÜNDAG, M. ÇELIK, Z. ÖZGEN, M. A. DEMIR, S. AYTÜRK, OSTEOPROTEGERIN AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND IN TYPE 2 DIABETIC NEPHROPATHY, Acta Medica Anatolia, vol. 5, no. 1, pp. 1-8, 1, 2017.
  • Kılıc I, Gungor K, Kurultak I, Ustundag S. Atypical Peritonitis Agents and Clinical Follow-Up in Peritoneal Dialysis Patients: Case Report. Turkiye Klinikleri J Intern Med 2016;1(3):147-9 (December 2016)
  • Endocarditis and Calcific Uremic Arteriolopathy: Is it a Coincidence or an Association? Case Report (March 2016)
  • .I. KILIÇ, K. GÜNGÖR, I. KURULTAK, S. ÜSTÜNDAG, Atypical Peritonitis Agents and Clinical Follow Up in Peritoneal Dialysis Patients Case Report, Turkiye Klinikleri Journal of Intern Medicine, vol. 1, no. 3, pp. 147-149, ISTANBUL-TÜRKIYE, 12, 2016.
  • R. AK, S. ÜSTÜNDAG, Ü. AYTEN, F. B. GÜLDIKEN, N. SÜT, Kronik Böbrek Hastaliginda Bilissel Fonksiyon Bozuklugu Diyaliz Modalitesinin Etkisi, The Turkish Nephrology, Dialysis and Transplantation Journal, vol. 24, no. 3, pp. 283-293, ANKARA-TÜRKIYE, 10, 2015.
  • S. ÜSTÜNDAG, Diyabet ve Diyabetik Nefropati Modeli, Türkiye Klinikleri Nefroloji Özel Dergisi, vol. 3, no. 3, pp. 63-71, ANKARA-TÜRKIYE, 2010.
  • .F. B. GÜLDIKEN, S. ÜSTÜNDAG, A. YILMAZ, H. ÇAKIR, Son dönem böbrek yetmezlikli hastada laktik asidoza bagli gelisen bilateral bazal gangliyon lezyonu, Türk Nöroloji Dergisi, vol. 15, pp. 44-49, -TÜRKIYE, 2009.
  • .S. ÜSTÜNDAG, Kronik böbrek hastaliginda karbonhidrat ve insulin metabolizmasi, Diabet Bilimi, vol. 6, pp. 81-85, -TÜRKIYE, 2008.

National Conference Proceedings

  • I. KURT, S. ÜSTÜNDAG, T. SIPAHI, A. AY, A. ÜSTÜNDAG, N. SÜT, TIP 2 DIYABETES MELLITUSLU HASTALARDA IL-8 -251TA GEN POLIMORFIZMININ NEFROPATI GELISIMINE ETKISI VARMIDIR?, 34. Ulusal Nefroloj, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya-TÜRKIYE. (October 2017)
  • .N. ALKANLI, A. AY, T. SIPAHI, T. GÜLYASAR, S. ÜSTÜNDAG, S. GÜLDIKEN, N. SÜT, Diyabetik Nefropati Gelisen Tip 2 Diyabetes Mellitus’lu Hastalarda Metilentetrahidrofolat Redüktaz A1298C Gen Polimorfizmi Genotip Dagilimlarinin Diyabetik Nefropati Gelisimine Etkisinin Belirlenmesi, 28-29. ULUSAL BIYOFIZIK KONGRESI, -TÜRKIYE. (September 2017)
  • A. AY, N. ALKANLI, T. SIPAHI, T. GÜLYASAR, S. ÜSTÜNDAG, S. GÜLDIKEN, N. SÜT, Insülin Reseptör 2 Gly1057Asp Gen Polimorfizmi Genotip Dagilimlarinin Tip 2 Diyabetes Mellitus’lu Hastalarda Diyabetik Nefropati Gelisimine Etkisinin Arastirilmasi, 28-29. ULUSAL BIYFOFIZIK KONGRESI, -TÜRKIYE. (September 2017)
  • V. K. ÇOBAN, S. ÜSTÜNDAG, A. ÜSTÜNDAG, N. SÜT, SON DÖNEM KRONIK BÖBREK HASTALARINDA HEMODIYALIZ TEDAVISININ KOGNITIF FONKSIYONLARA ETKISI, 34. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, ANTALYA-TÜRKIYE.
  • .M. M. ZEREY, I. KILIÇ, S. N. KODAL, I. KURT, I. KURULTAK, S. ÜSTÜNDAG, Tekrarlayan renal arter trombozu ataklari ile seyreden antifosfolipid sendrom olgusu, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 73-, -TÜRKIYE.
  • .I. KILIÇ, S. ÜSTÜNDAG, I. KURULTAK, Yogun bakimda takip edilen hastada ilaca bagli tekrarlayan akut böbrek hasari, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 74-, -TÜRKIYE.
  • .S. N. KODAL, M. M. ZEREY, A. TOPAL, K. K. SAÇAR, I. KURULTAK, S. ÜSTÜNDAG, Hemodiyaliz uygulanan hastada ilaca bagli bülloz pemfigoid, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 78-, -TÜRKIYE.
  • .K. K. SAÇAR, S. ÜSTÜNDAG, A. TOPAL, I. KILIÇ, I. KURULTAK, Bonzai kullanimina bagli miyoglobinürik nakut böbrek yetmezligi, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 80-, -TÜRKIYE.
  • .I. KILIÇ, M. ÇELIK, S. ÜSTÜNDAG, S. GÜLDIKEN, I. KURULTAK, Y. B. BÜLBÜL, Meyan kökü ekstresi kullanimi sonrasi gelisen hipokalemi ve hipertansiyon olgu sunumu, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 108-, -TÜRKIYE.
  • .B. H. DAG, S. ÜSTÜNDAG, I. KILIÇ, I. KURULTAK, Reno pulmoner sendrom RPS ile basvuran katastrofik antifosfolipid sendromu olgusu, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 72-, ANAKARA-TÜRKIYE.
  • .I. KILIÇ, M. ÇELIK, S. ÜSTÜNDAG, S. GÜLDIKEN, I. KURULTAK, Y. B. BÜLBÜL, S. AYTÜRK, Görüntülenemeyen sürrenal adenoma bagli sekonder hipertansiyon Adrenal venöz örneklemenin yeri, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 108-, ANTALYA-TÜRKIYE.
  • .S. ÜSTÜNDAG, Saglik ve su oturumu Ne kadar su içelim, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, ANTALYA-TÜRKIYE.
  • .S. ÜSTÜNDAG, Literatürde yeni ne var Klinik nefroloji ve hipertansiyon, 38. Nefroloj, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, ANTALYA-TÜRKIYE.
  • .I. KILIÇ, Y. DÜRMÜS, S. ÜSTÜNDAG, I. KURULTAK, Tromboz profilaksisi yapilmakta olan diyazliz hastasinda ortaya çikan atipik bir hematom vakasi, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 68-, Ankara-TÜRKIYE.
  • .I. KURT, A. ÜSTÜNDAG, I. KILIÇ, S. ÜSTÜNDAG, Böbrek transplantasyonu sonrasi kronik rejeksiyon gelismesi ile hemodiyalize beslenen hastada hepatit B infeksiyonu, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 71-, ANKARA-TÜRKIYE.
  • .B. H. DAG, Y. DÜRMÜS, S. ÜSTÜNDAG, I. KILIÇ, I. KURULTAK, Renal transplantli olguda gelisen yaygin cilt döküntüsü, 33. Ulusal Nefroloji, Hipertasiyon, Diyaliz ve Böbrek Hastaliklari Kongresi, vol. 25, no. 3, pp. 164-, ISTANBUL-TÜRKIYE.
  • .I. KILIÇ, Y. DÜRMÜS, S. ÜSTÜNDAG, I. KURULTAK, Bülloz cilt lezyonlari nefrit pansitopeni ve nöbet ile ortaya çikan hizli gidisli bir sistemik lupus eritematozus vakasi, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 31-, Ankara-TÜRKIYE.
  • .I. KILIÇ, M. ÇELIK, S. ÜSTÜNDAG, S. GÜLDIKEN, I. KURULTAK, Y. B. BÜLBÜL, S. AYTÜRK, Görüntülenemeyen sürrenal adenoma bagli sekonder hipertansiyon Adrenal venöz örneklemenin yeri, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 108-, ANTALYA-TÜRKIYE.
  • .B. H. DAG, Y. DÜRMÜS, S. ÜSTÜNDAG, I. KILIÇ, I. KURULTAK, Renal transplantli olguda gelisen yaygin cilt döküntüsü, 33. Ulusal Nefroloji, Hipertasiyon, Diyaliz ve Böbrek Hastaliklari Kongresi, vol. 25, no. 3, pp. 164-, ISTANBUL-TÜRKIYE.
  • .I. KILIÇ, Y. DÜRMÜS, S. ÜSTÜNDAG, I. KURULTAK, Bülloz cilt lezyonlari nefrit pansitopeni ve nöbet ile ortaya çikan hizli gidisli bir sistemik lupus eritematozus vakasi, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 31-, Ankara-TÜRKIYE.
  • .I. KILIÇ, Y. DÜRMÜS, S. ÜSTÜNDAG, I. KURULTAK, Tromboz profilaksisi yapilmakta olan diyazliz hastasinda ortaya çikan atipik bir hematom vakasi, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 68-, Ankara-TÜRKIYE.
  • .I. KURT, A. ÜSTÜNDAG, I. KILIÇ, S. ÜSTÜNDAG, Böbrek transplantasyonu sonrasi kronik rejeksiyon gelismesi ile hemodiyalize beslenen hastada hepatit B infeksiyonu, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 71-, ANKARA-TÜRKIYE.
  • .B. H. DAG, S. ÜSTÜNDAG, I. KILIÇ, I. KURULTAK, Reno pulmoner sendrom RPS ile basvuran katastrofik antifosfolipid sendromu olgusu, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 72-, ANAKARA-TÜRKIYE.
  • .M. M. ZEREY, I. KILIÇ, S. N. KODAL, I. KURT, I. KURULTAK, S. ÜSTÜNDAG, Tekrarlayan renal arter trombozu ataklari ile seyreden antifosfolipid sendrom olgusu, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 73-, -TÜRKIYE.
  • .I. KILIÇ, S. ÜSTÜNDAG, I. KURULTAK, Yogun bakimda takip edilen hastada ilaca bagli tekrarlayan akut böbrek hasari, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 74-, -TÜRKIYE.
  • .S. N. KODAL, M. M. ZEREY, A. TOPAL, K. K. SAÇAR, I. KURULTAK, S. ÜSTÜNDAG, Hemodiyaliz uygulanan hastada ilaca bagli bülloz pemfigoid, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 78-, -TÜRKIYE.
  • .K. K. SAÇAR, S. ÜSTÜNDAG, A. TOPAL, I. KILIÇ, I. KURULTAK, Bonzai kullanimina bagli miyoglobinürik nakut böbrek yetmezligi, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 80-, -TÜRKIYE.
  • .I. KILIÇ, M. ÇELIK, S. ÜSTÜNDAG, S. GÜLDIKEN, I. KURULTAK, Y. B. BÜLBÜL, Meyan kökü ekstresi kullanimi sonrasi gelisen hipokalemi ve hipertansiyon olgu sunumu, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 108-, -TÜRKIYE.
  • .I. KILIÇ, M. ÇELIK, S. ÜSTÜNDAG, S. GÜLDIKEN, I. KURULTAK, Y. B. BÜLBÜL, S. AYTÜRK, Kabergoline bagli hiperpotasemi, 18. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 109-, ANTALYA-TÜRKIYE.
  • Kılıç İ, Kurultak I, Aktaş GE, Üstündağ S, Ege T, Sarıkaya A. Peritoneal Diyaliz hastasında by-pass sonrası plevraperitoneal şunt. (April 2015)
  • C. Sevinç, G. Yılmaz, S. Üstündağ, Y.C. Yavuz, “Kronik böbrek yetmezliğinde ürik asit düzeyi ve ilişkili faktörler,” 17. Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, 74 (PS-048), Antalya, (2015). (April 2015)
  • Kurultak, İ., İ. Kılıç, H. Gençhellaç, S. Üstündağ, , “Hemodiyaliz hastasında atipik karın ağrısı nedeni: Rektus abdominis kılıfı içine kanama,” 17. Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, 72 (PS-045), Antalya, (2015). (April 2015)
  • Kurultak, İ., İ. Kılıç, B. Sezer, S. Tuncel, E. Taştekin, S. Üstündağ, , “Üremik kalsifik arteriolopatinin nadir bir presentasyonu: Endokardit,” 17. Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, 67 (PS-038), Antalya, (2015). (April 2015)
  • Yılmaz, G., S. Üstündağ, C. Sevinç, İ.Ö. Özkara, R. Akgün, “Tip 2 Diyabetes Mellituslü hastalarda diyaliz yeterliliği ve inflamasyonla ilişkisi,” 17. Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, 48 (PS-001), Antalya, (2015). (April 2015)
  • .I. KURULTAK, I. KILIÇ, B. SEZER, A. S. TUNCEL, E. TASTEKIN, S. ÜSTÜNDAG, Üremik kalsifik arteriolopatinin nadir bir presentasyonu Endokardit, 17. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 67-, ANKARA-TÜRKIYE.
  • .I. KURULTAK, I. KILIÇ, H. GENÇHELLAÇ, S. ÜSTÜNDAG, Hemodiyaliz hastasinda atipik karin agrisi nedeni Rektus abdominis kilifi içine kanama, 7. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 72-, ANKARA-TÜRKIYE.
  • .C. SEVINÇ, G. YILMAZ, S. ÜSTÜNDAG, Y. Y. COSKUN, Kronik böbrek yetmezliginde ürik asit düzeyi ve iliskili faktörler, 17. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 74-, ANKARA-TÜRKIYE.
  • .S. ÜSTÜNDAG, Kronik bo brek hastalarinda kan örneklemesinde dikkat edilecek hususlar, Türk Nefroloji Dernegi Nefroloji Kis Okulu 2015, MAGOSA-KKTC.
  • .S. ÜSTÜNDAG, Antihipertansif ilacimi ne zaman almaliyim Aksam, 17. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, ANTALYA-TÜRKIYE.
  • .I. KILIÇ, I. KURULTAK, G. L. A. EGE, S. ÜSTÜNDAG, T. EGE, A. SARIKAYA, Peritoneal Diyaliz hastasinda by pass sonrasi plevraperitoneal sunt, 27. Ulusal Nükleer Tip Kongresi, vol. 1, pp. 66-, ADANA-TÜRKIYE.
  • .G. YILMAZ, S. ÜSTÜNDAG, C. SEVINÇ, Ö. Ö. IREM, A. RUHAN, Tip 2 Diyabetes Mellituslü hastalarda diyaliz yeterliligi ve inflamasyonla iliskisi 17 Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi 48 PS 001 Antalya 2015, 17. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 48-, ANKARA-TÜRKIYE.
  • .I. KURULTAK, I. KILIÇ, B. SEZER, A. S. TUNCEL, E. TASTEKIN, S. ÜSTÜNDAG, Üremik kalsifik arteriolopatinin nadir bir presentasyonu Endokardit, 17. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 67-, ANKARA-TÜRKIYE.
  • .I. KURULTAK, I. KILIÇ, H. GENÇHELLAÇ, S. ÜSTÜNDAG, Hemodiyaliz hastasinda atipik karin agrisi nedeni Rektus abdominis kilifi içine kanama, 7. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 72-, ANKARA-TÜRKIYE.
  • .C. SEVINÇ, G. YILMAZ, S. ÜSTÜNDAG, Y. Y. COSKUN, Kronik böbrek yetmezliginde ürik asit düzeyi ve iliskili faktörler, 17. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 74-, ANKARA-TÜRKIYE.
  • .S. ÜSTÜNDAG, Kronik bo brek hastalarinda kan örneklemesinde dikkat edilecek hususlar, Türk Nefroloji Dernegi Nefroloji Kis Okulu 2015, MAGOSA-KKTC.
  • .S. ÜSTÜNDAG, Antihipertansif ilacimi ne zaman almaliyim Aksam, 17. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, ANTALYA-TÜRKIYE.
  • .I. KILIÇ, I. KURULTAK, G. L. A. EGE, S. ÜSTÜNDAG, T. EGE, A. SARIKAYA, Peritoneal Diyaliz hastasinda by pass sonrasi plevraperitoneal sunt, 27. Ulusal Nükleer Tip Kongresi, vol. 1, pp. 66-, ADANA-TÜRKIYE.
  • .G. YILMAZ, S. ÜSTÜNDAG, C. SEVINÇ, Ö. Ö. IREM, A. RUHAN, Tip 2 Diyabetes Mellituslü hastalarda diyaliz yeterliligi ve inflamasyonla iliskisi 17 Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi 48 PS 001 Antalya 2015, 17. Ulusal Hipertansiyon ve Böbrek Hastaliklari Kongresi, pp. 48-, ANKARA-TÜRKIYE.

National Conferences and Symposiums

  • GEBELİK VE BÖBREK Oturum Başkanları: Dr. Sedat Üstündağ, Dr. Gülizar Şahin, 40. Ulısal Nefroloji Kongresi Aralık 2023, Antalya (December 2023)
  • Türk Nefroloji Derneği’nin 39. Ulusal Nefroloji Kongresi 9-13 Kasım 2022 "BİLİMSEL ARAŞTIRMADAN MAKALEYE YOLCULUK *Oturum Başkanları : Rümeyza Kazancıoğlu Sedat Üstündağ (November 2022)
  • .S. ÜSTÜNDAG, LITERATÜR GÜNCELLEMESI: DIYALIZ, 34. Ulusal Nefroloji, Hpertansiyon, Diyaliz ve Transplantasyon Kongresi, -TÜRKIYE. (October 2017)
  • S. ÜSTÜNDAG, Diyalizde kateter kullanimi ve komplikasyonlari, Türk Nefroloji Dernegi Kis Okulu 2017, -TÜRKIYE. (April 2017)
  • Oral Presentation Chairman: Assoc. Prof. Sedat Üstündağ 30th National Congress of Nephrology, Hypertension, Dialysis and Transplantation. 13-17 Kasım 2013 Belek Antalya (November 2013)
  • Is Obesity a Reliable Marker ? Speaker: Dr. Sedat Üstündağ Chairmans: Dr. Fatoş Yalçınkaya, Dr. Oktay Oymak XV. National Kidney Disases and Hypertension Congress. 24-28 April 2013 Belek Antalya (April 2013)

Doctoral Dissertations Advised

  • SÜREĞEN DÜZENLİ DİYALİZ TEDAVİSİ UYGULANMAKTA OLAN HASTALARDA SERUM İRİSİN DÜZEYİ İLE ATEROSKLEROZ GELİŞİMİ İLİŞKİSİNİN ARAŞTIRILMASI. Dr. Selin Batmaz Demir Uzmanlık Tezi (December 2022)
  • Diyabetik Nefropatide Ateroskleroz; Etkileyen Faktörler ve İrisinin Yeri. Dr. Bengisu Akyol Tıpta uzmanlık tezi (March 2022)

Master`s Theses Advised

  • The Effect of Hemodialysis on Cognitive function in Patient with End Stage Renal Disease (August 2016)
  • THE RELATIONSHIP BETWEEN FIBROBLAST GROWTH FACTOR 23 AND ATHEROSCLEROSIS IN CHRONIC KIDNEY DISEASE (August 2013)

Editorial Positions

  • Turkish Journal of Nephrology (January 2023)
  • Turkish Journal of Nephrology (January 2023)
  • Balkan Medical Journal (January 2023)
  • Turkish Journalof Nephrology Associate Editor (January 2022)
  • Balkan Medical Journal Associate Editor (January 2022)
  • International Medical Journal Medicus, Editorial Boards Member
  • Turkish Dialysis Nephrology Transplantation Journal, Editorial Board Member, Associate Editor
  • Balkan Medical Journal, Editorioal Board Member, Associate Editor
  • Balkan Medical Journal, Associate Edıtor, Editorial Board Member (January 2017)
  • Balkan Medical Journal, Associate Editor, Editorial Board Member (January 2017)
  • International Medical Journal Medicus Editorial Board Member (January 2017)

Referee Positions

  • 40. Ulusal Nefroloji Kongresi , 6-10 Aralık 2023 Antalya, Bişldiri Derğerlendirme Jüri Üyeliği (December 2023)
  • Prof. Dr. İdris Şahin Amasya Üniversitesi Prof. atama jürisi (November 2023)
  • Can Özgür UAK Dpçentlik Eser İnceleme Jürisi (July 2023)
  • Eda Altun UAK Doçentlik eser incelemesi (May 2023)
  • Doç. Dr. Mahmut Çeri Prof. rama Jüri Üyeliği Pamukkale Üniversitesi (January 2023)
  • Manuscript ID: BalkanMedJ-2022-10-78Digital necrosis in granulomatosis with polyangiitisType: Clinical Image Submitted: 2022-10-20Reviewer: Prof. Sedat Üstündağ Date returned: 2022-12-12 (November 2022)
  • BalkMedJ-2017-1201 Vitamin E improves Doxorubicin induced Nephrotoxcisty; possible underlying mechanisms (December 2017)
  • BalkMedJ-2017-1073 Assessment of Relationship Between Serum Vitamin D Levels and Metabolic Syndrome Components in Hemodialysis Patients (September 2017)
  • BalkMedJ-2017-1003 Abnormal Flotation of Separator Gel in Blood Test Tubes in Three Hemodialysis Patients with Intradialytic Hypotension (September 2017)
  • BalkMedJ-2017-0876 The clinical importance of cystatin c and hepatic artery resistive index in liver cirrhosis (July 2017)
  • BalkMedJ-2017-0838 Bone mineral density and vitamin D status in children in remission phase of steroid sensitive nephrotic syndrome (July 2017)
  • BalkMedJ-2017-0710 Noninfectious Diarrhea in a Patient on Continous Ambulatory Peritoneal Dialysis Using 7.5% Icodextrin (June 2017)
  • BalkMedJ-2017-0694 Hopelessness and Quality Of Life Levels in Hemodialysis Patients (June 2017)
  • BalkMedJ-2017-0427 AN INVESTIGATION OF ACUTE EFFECTS AT VARIOUS DOSES OF MALATHION ON GLUCOSE HOMEOSTASIS AND INSULIN RESISTANCE IN RAT LIVER, PANCREAS AND SERUM. (June 2017)
  • BalkMedJ-2017-0606 EFFECTS OF HIGH ULTRAFİLTRATION RATE ON LEFT ATRIUM VOLUME INDEX IN CHRONIC HEMODIALYSIS PATIENTS (June 2017)
  • BalkMedJ-2017-0568 Unexpected side effect of Eculizumab in an aHUS patient: Hepatotoxicity (May 2017)
  • BalkMedJ-2017-0384 Apelin: A potential novel serum biomarker for early diabetic nephropathy in patients with type 2 diabetes (April 2017)
  • BalkMedJ-2017-0278 Reference interval evaluation of hematological parameters and effect of moderate high altitude on these parameters (March 2017)
  • BalkMedJ-2017-0299 The Effects of Oral Antidiabetic Drugs such as Metformin, Rosiglitazone, and Repaglinide on Diabetic Angiopathy. (March 2017)
  • BalkMedJ-2017-0139 The impact of hepatitis B and C infections on graft and liver functions in kidney transplantation: a single center experience in Turkey (March 2017)
  • BalkMedJ-2017-0284 Factors Related to Physical Activities Using the Theory of Planned Behavior in Iranian Rural Women with Hypertension (March 2017)
  • BalkMedJ-2017-0229 Pulmonary function abnormalities and Type 2 diabetes mellitus – a cross sectional study (March 2017)
  • BalkMedJ-2017-0174 Ultrasonographic Assessment of Renal Size in Normal Children: Gender and Age induced Differences (March 2017)
  • BalkMedJ-2017-0075 Higher Cystatin C is associated with an increased risk for metabolic syndrome (March 2017)
  • BalkMedJ-2017-0040 THE EFFECTS OF BAICALIN ON MYOGLOBINURIC ACUTE RENAL FAILURE IN RATS (March 2017)
  • Elevated Ischemic Modified Albumin: Could it be a warning sign for an Acute Kidney Injury? BalkMedJ-2016-1762 (March 2017)
  • BalkMedJ-2017-0121 The Effect Of Short Term Alpha Lipoic Acid Administration On Adiponectin And Body Weight In Type 2 Diabetes Mellitus Patients (February 2017)
  • BalkMedJ-2017-0052 Subcutaneous Gentamicin Injection Around The Cuff In Treatment of Resistant Exit Site Infection In Peritoneal Dialysis Patients: a Pilot Study (February 2017)
  • BalkMedJ-2017-0033 Asymptomatic multicentric Castleman disease in lupus nephritis: A case report (January 2017)
  • BalkMedJ-2016-2006 Bilateral Non-Traumatic Recurrent Page Kidney (January 2017)
  • BalkMedJ-2016-2000 Remote preconditioning might have protective effect for kidney in heart surgery (January 2017)
  • BalkMedJ-2016-1930 THE RELATIONSHIP BETWEEN SERUM ASYMMETRIC DIMETHYLARGININE LEVELS AND CARDIOVASCULAR RISK FACTORS IN CHILDREN WITH NEPHROTIC SYNDROME (January 2017)
  • BalkMedJ-2016-1978 TRANSPLANTATION OF SİNGLE MISMATCH HEMATOPOIETIC STEM CELLS WITH THIRD PARTY MESENCHYMAL STEM CELLS FOR SEVERE APLASTIC ANEMIA: A CASE REPORT AND MINIREVIEW (January 2017)
  • BalkMedJ-2016-1937 Is there a relationship between serum fetuin A levels and hematological parameters with Behcet disease activity? (January 2017)
  • BalkMedJ-2016-1854 Role of the -1082A/G polymorphism in IL10 for the renal damage in the congenital anomalies of the kidney and urinary tract (January 2017)
  • BalkMedJ-2016-1764 A role of the endothelial nitric oxide system in acute renal colic caused by ureteral stone (January 2017)
  • BalkMedJ-2016-0284 entitled "ACUTE RENAL FAILURE AND THIOL-DISULFIDE HOMEOSTASIS (November 2016)
  • Yrd. Doç. Dr. Abdulmecit Yıldız. 2015 Ekim Üniversiteler Arası Kurul Başkanlığının 22798904-204 sayılı yazıları ile Dönemi Doçentlik Başvurusu eser inceleme jüri üyeliği. Mayıs 2016 (May 2016)
  • Dr. Mehmet Nuri Turan. Üniversiteler Arası Kurul Başkanlığının 22798904-204 sayılı yazıları ile 2015 Ekim Dönemi Doçentlik Sınav Başvurusu Eser İnceleme Jüri Üyeliği. Mayıs 2016 (May 2016)
  • JMCR-D-16-00027 C3 Mesangial Proliferative Glomerulonephritis Initially Presenting with Hemolytic Uremic Syndrome: A case report Journal of Medical Case Reports (April 2016)
  • Doç. Dr. Dede Şit. İstanbul Kemerburgaz Üniversitesi Rektörlüğü 98128203-302.14.05 sayılı yazılı ile Profesörlük başvurusu eser inceleme jürisi. Mart 2016 (March 2016)
  • 'Protective Effect of Quinacrine Against Glycerol-Induced Acute Kidney Injury in Rats. BMJ Nephrology BNEP-D-15-00210 (December 2015)
  • Uzm. Dr. Gülay TAŞTAN; T.C. Fatih Üniversitesi Tıp Fakültesi Yardımcı Doçentlik Jürisi (26/10/2015; 38918275/1367) (November 2015)
  • Renal Failure Due to Status Epilepticus Ulusal Dergi: CausaPedia Tarih: 4 Temmuz 2013 (July 2013)
  • BalkMedJ-2018-1517. High adiponectin hormone Modulates Blood Erythroid Parameters and Its Relation with EPO in Patients With Diabetic Nephropathy . (October 2000)
  • BalkMedJ-2018-1492. Association of lipid profile and kidney function in children and adolescents: The CASPIAN-V Study. (September 2000)
  • BalkMedJ-2018-1359. Evaluation of kidney function and proteinuria in patients with Hashimoto’s Thyroiditis. (August 2000)
  • BalkMedJ-2018-1351. Early And Late Effects Of Percutaneous Nephrolithotomy On Renal Functions According To Basal Renal Function Reserve. (August 2000)
  • BalkMedJ-2018-1110. Effects of low-dose aspirin on inhibition of platelet aggregation in patients with rheumatoid arthritis. (June 2000)
  • BalkMedJ-2018-1098. Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis. (June 2000)
  • BalkMedJ-2018-0938. AMINO ACID AND ICODEXTRIN-BASED SOLUTIONS MAY INCREASE SERUM GHRELIN LEVELS IN PERITONEAL DIALYSIS. (May 2000)
  • BalkMedJ-2018-0895. THE SAFETY AND EFFICACY OF THE LEAST INCOMPATIBLE CROSS-MATCH TRANSFUSION USING IN VIVO COMPATIBILITY TESTS. (May 2000)
  • BalkMedJ-2018-0894. MAGNESIUM LEVELS IN CHILDREN WITH CHRONIC KIDNEY DISEASE STAGES 1‒3 (May 2000)
  • BalkMedJ-2018-0865. A SPECIFIC APPROACH OF HYPERTENSION MANAGEMENT AT ELDERLY. (May 2000)
  • BalkMedJ-2018-0852. Can Serum NGAL Replace Serum Creatinine for Prediction of Acute Kidney Injury Following Laparoscopic Partial Nephrectomy? Prospective Clinical Study. (May 2000)
  • BalkMedJ-2018-0713. SHORT TERM EFFECT OF LOW PROTEIN DIET ON CHRONIC KIDNEY DISEASE PROGRESSION IN PATIENTS WITH CKD G3a STAGE . (April 2000)
  • BalkMedJ-2018-0693. Comparison of central venous hemodialysis catheter-related infection rates between intermittent hemodialysis and continuous renal replacement therapy .
  • BalkMedJ-2018-0644. Leptospirosis with acute renal failure and vasculitis with peripheral gangrene of the lower extremities: a case report.
  • BalkMedJ-2018-0592. Nephroprotective effect of Costus afer on lead induced kidney damage in albino rats.
  • BalkMedJ-2018-0576. Morphometric analysis of structural renal alterations and beneficial effects of aminoguanidine in acute kidney injury induced by cisplatin in rats.
  • BalkMedJ-2018-0522. Evaluation of the Relation Between Fluid Consumption Habits and Metabolic Syndrome.
  • BalkMedJ-2018-0501. TIMI Risc Index Predicts Contrast Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention.
  • BalkMedJ-2018-0497. An Unusual Presentation of T-Cell Lymphoblastic Lymphoma with Isolated Renal Involvement.
  • BalkMedJ-2018-0465. Acute renal failure and management in chronic renal failure in a hemophilia B patient using Hibiscus tea (Hibiscus Sabdariffa) and diclofenac.
  • BalkMedJ-2018-0463. The value of Serum Uric Acid in predicting adverse pregnancy outcomes of women with hypertensive disease of pregnancy.
  • BalkMedJ-2018-0447. The relationship between urotensin II and insulin resistance in women with gestational diabetes mellitus.
  • BalkMedJ-2018-0440. The approach to phytotherapy applications: a case report of hyperkalemia .
  • BalkMedJ-2018-0354. Current status of organ donation in Izmir, Turkey: Identifying possible obstacles and future solutions in a developing country.
  • BalkMedJ-2018-0342. Hypertension In Patients With Sleep Disordered Breathing: Cause Or Result? “A Cross-Sectional Analysis”.
  • BalkMedJ-2018-0331. A RARE CAUSE OF BILATERAL HYDROURETERONEPHROSIS AND ANURIA: A CASE OF INFLAMMATORY ILIAC ANEURYSM.
  • BalkMedJ-2018-0296. Physical Activity, Insulin Sensitivity and Metabolic Control in Patients with Type 1 DM. A Cross-Sectional Single-Center Study among Turkish Patients.
  • BalkMedJ-2018-0290. An Overlooked Case of a Treatable Hyperinsulinemic Hypoglycemia: Congenital Glycosylation Defect Type Ibç
  • BalkMedJ-2018-0253. EFFECTS OF ACUTE SUBMAXIMAL EXERCISE ON BLOOD COAGULATION AND FIBRINOLYTIC SYSTEMS IN MALE PATIENTS WITH TYPE 2 DIABETES MELLITUS.
  • BalkMedJ-2018-0196. Two-year follow-up of hypertensive patients treated with fixed combination of lisinopril and hydrochlorothiazide
  • BalkMedJ-2018-0173. Comorbidity associated with chronic kidney disease(CKD) in patients undergoing hemodialysis and variation in biochemical parameters among both genders.
  • BalkMedJ-2018-0160. The Role Of Oncostatin M In Chronic Inflammatory Process Of Insulin Resistance
  • BalkMedJ-2018-0148 . FAT DISTRIBUTION AND METABOLIC PROFILE IN SUBJECTS WITH HASHIMOTO’S THYROIDITIS
  • BalkMedJ-2018-0141 The effect of bone-marrow biopsy to the serum sodium level
  • BalkMedJ-2018-0136. Filiform polyposis in ulcerative colitis: A rare pediatric case .
  • BalkMedJ-2018-0093. PRUNE-BELLY SYNDROME – COULD EARLY INDUCED LABOUR PROVE A VIABLE ALTERNATIVE TO SLOWING CHRONIC KIDNEY DISEASE PROGRESSION?
  • BalkMedJ-2018-0085. Role of Vildagliptin in elevating serum VEGF and modulation of high blood pressure in type-2 diabetic Egyptian patients with hypertension
  • BalkMedJ-2018-0075. Incretin levels in patients with nonfunctional adrenal incidentaloma
  • BalkMedJ-2018-0047. Evaluation of Two New Anthropometric Indices (A Body Shape Index and Body Roundness Index) in Obese Individuals
  • BalkMedJ-2018-0041. Can Body Shape Index in Stage III-IV Chronic Kidney Disease be Indicative of Obesity-Associated Inflammation?
  • BalkMedJ-2018-0029 Serum fetuin-A is associated with components of MIAC (malnutrition, inflammation, atherosclerosis, calcification) syndrome in chronic kidney disease
  • BalkMedJ-2018-0009. Multifocal dystonia induced by levofloxacin
  • BalkMedJ-2017-1350 MUSHROOM POISONING CASES FROM AN EMERGENCY DEPARTMENT IN CENTRAL ANATOLIA: COMPARISON AND EVALUATION OF WILD AND CULTIVATED MUSHROOM POISONING

Projects

  • Trakya Üniversitesi Tıp Fakültesi Eğitici Gelişimi Programının Uygulanması. TUBAP 2015.218 (July 2016)
  • .Yüksekögretim Kurumlari tarafindan destekli bilimsel arastirma projesi, TRAKYA ÜNIVERSITESI SAGLIK ARASTIRMA VE UYGULAMA MERKEZINDE TAKIP EDILEN TIP 2 DIYABETLI HASTALARDA INTERLÖKIN 8 251A T POLIMORFIZMININ NEFROPATI GELISIMINE ETKISININ ARASTIRILMASI, Tip 2 Diyametes Mellitusu olan hastalarda Interlökin 8 251A T polimorfizminin nefropati gelisimine etkisinin arastirildigi çalisma projesi, Baslangiç Tarihi: 07.03.2016, Bitis Tarihi : 07.03.2017,Kurumu: TRAKYA ÜNIVERSITESI, Tamamlandi.
  • RELATIONSHIP BETWEEN ATHEROSCLEROSIS AND CIGARETTE SMOKING AND GENETIC POLYMORPHISM (August 2015)
  • THE EFFECT OF ANGIOTENSINOGEN M235T/T164M AND ANGIOTENSIN TYPE 1 FECEPTOR A1166C POLYMORPHISMS ON DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATINETS WITH TYPE 2 DIBATES MELLITUS (July 2015)
  • Yüksekögretim Kurumlari tarafindan destekli bilimsel arastirma projesi, Trakya Üniversitesi Tip Fakültesi Egitici Gelisimi Programinin Uygulanmasi, Trakya Üniversitesi Tip Fakültesinde uygulamali egitimin gelistirlmesi ve verimliligin artirilmasi, Baslangiç Tarihi: 28.12.2015, Bitis Tarihi : 13.07.2016,Kurumu: TRAKYA ÜNIVERSITESI, Tamamlandi.
  • .Yüksekögretim Kurumlari tarafindan destekli bilimsel arastirma projesi, TIP 2 DIYABETES MELLITUSLU HASTALARDA ANJIYOTENSINOJEN M235T T174M VE ANJIYOTENSIN TIP 1 RESEPTÖR A1166C POLIMORFIZMLERININ DIYABETIK NEFROPATI GELISIMINE ETKISININ ARASTIRLMASI, TIP 2 DIYABETES MELLITUSLU HASTALARDA ANJIYOTENSINOJEN M235T T174M VE ANJIYOTENSIN TIP 1 RESEPTÖR A1166C POLIMORFIZMLERININ DIYABETIK NEFROPATI GELISIMINE ETKISININ ARASTIRLMASI, Baslangiç Tarihi: 23.06.2014, Bitis Tarihi : 21.07.2015,Kurumu: TRAKYA ÜNIVERSITESI, Tamamlandi.
  • THE RELATIONSHIP BETWEEN FIBROBLAST GROWTH FACTOR 23 AND ATHEROSCLEROSIS IN CHRONIC KIDNEY DISEASE (April 2013)
  • ATHEROGENICITY IN END STAGE RENAL DISEASE AND THE ROLE OF ASYMETRIC DIMETHYLARGININE (January 2013)
  • .Yüksekögretim Kurumlari tarafindan destekli bilimsel arastirma projesi, SIGARA NIN ATEROSKLEROZLA ILISKISI VE GENETIK POLIMORFIZM, SIGARA NIN ATEROSKLEROZLA ILISKISI VE GENETIK POLIMORFIZM, Baslangiç Tarihi: 31.12.2012, Bitis Tarihi : 12.08.2015,Kurumu: TRAKYA ÜNIVERSITESI, Tamamlandi.

Other

  • Doç. Dr. Mevlüt Çeri (Pamukkale Üniversitesi Prof. atama jüri üyeliği) (December 2022)
  • Dr. Ercan TÜRKMEN UAK Doçentlik jüri üyeliği (December 2022)
  • Dr. İlhan Kılıç Dr. Öğretim Üyesi Jüri Üyeliği (September 2022)